首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1629828

全球整形外科市场 - 2024-2031

Global Plastic Surgery Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球整形外科市场规模达697亿美元，预计2031年将达到1,587亿美元，2024-2031年预测期间复合年增长率为11.1%。

整形外科是一门外科专业，涉及改善人的外观以及重建因疾病、创伤或先天性疾病造成的脸部和身体组织缺陷。整形手术可以恢復和改善功能以及外观。它可以涉及除中枢神经系统之外的任何解剖部位的手术。称为整形外科的外科专业涉及人体的重建、增强或改变。整容手术和重建手术是整形手术的两个子类别。

此外，由于老年人口的增加、微创手术的采用、手术成本的降低、市场上授权服务提供者数量的增加以及新产品推出数量的增加，消费者对这些整形手术的需求不断增长。市场规模扩大。由于北美地区研究的发展，市场对北美地区产品的需求不断增长。 Allergan Aesthetics (AbbVie Inc.)、Merz Aesthetics、Cynosure LLC 等重要竞争对手在市场上积极运作。

市场动态：

驱动程式和限制

整形手术的需求不断增加

对整形外科手术的需求不断增长预计将成为全球整形外科市场成长的重要因素。老年人口的增加、疤痕和受伤数量的增加、技术进步、最近的推出和批准等因素增加了对整形外科手术的需求。不断增长的老年人口预计将对全球整形外科市场产生重大影响。随着预期寿命的延长和老年人口的增长，越来越需要美容疗程来解决与年龄相关的问题，例如皱纹、皮肤下垂和体积损失。作为改善外观的一种方式，整容、真皮填充剂和肉毒桿菌注射在老年人中越来越受欢迎。

交通事故和烧伤发生率的上升导致越来越多的患者需要疤痕治疗，增加了对疤痕修復和美容整形手术的需求。例如，根据世界卫生组织统计，每年估计有 18 万人因烧伤而死亡。绝大多数发生在低收入和中等收入国家。在印度，每年有超过 100 万人中度或重度烧伤。

由于美容和改善外观的需要，进行的手术数量日益增加。例如，根据美国整形外科医师协会的数据，2023年，美国总共进行了304,181例隆乳手术、347,782例抽脂手术以及120,747例眼睑手术和手术。

老年人口的增加是预测期内市场成长的主要驱动力。随着全球老年人口的增加，对整形手术的需求也增加。例如，根据联合国预测，2023年，全球60岁以上人口将达10.6亿，预计2030年同年龄组人口将增至13.3亿。例如，2024年9月，艾伯维公司旗下的艾尔建美容公司宣布，肉毒桿菌（onabotulinumtoxinA）现已在中国上市，用于治疗咬肌优势症（MMP）。咬肌是下脸的咀嚼肌之一，它的优点可以导致下脸宽而方形1。中国国家药品监督管理局 (NMPA) 最近批准了 BOTOX 化妆品，用于暂时增强成人显着至极其显着的 MMP 的外观。 BOTOX Cosmetic 是中国第一个批准用于 MMP 的神经毒素，它包括规定的剂量、强大的临床资料以及与标籤治疗相关的医生培训。

与整形手术相关的副作用

与整形手术相关的副作用等因素预计将阻碍全球整形外科市场。感染、严重出血、疤痕、麻醉或植入相关的不良反应都是常见问题。这些危险不仅危及病人安全，还可能导致对结果不满意，导致从业者承担法律责任并损害其职业声誉。例如，根据美国国立卫生研究院的数据，正在报告持续性肉芽肿和感染等长期不良事件。这些可能是由于无菌操作不严格或生物膜的形成造成的。填充剂的不良事件不仅可能持续存在，而且可能导致严重的併发症，例如永久性失明。

Plastic surgery is a surgical specialty involved with both the improvement of a person's appearance and the reconstruction of facial and body tissue defects due to illness, trauma, or birth disorders. Plastic surgery restores and improves function, as well as appearance. It can involve surgery on any part of the anatomy, except the central nervous system. A surgical specialty known as plastic surgery deals with the reconstruction, augmentation, or change of the human body. Cosmetic surgery and reconstructive surgery are the two subcategories of plastic surgery.

Moreover, rising consumer demand for these plastic procedures due to the increasing geriatric population, adoption of minimally invasive procedures, reduced procedural costs, an increase in the number of authorized service providers in the market, and an increase in the number of new product launches are driving up the plastic surgery market size. The market is experiencing a growth in demand for products from North American areas as a result of the development of research in these fields. Significant competitors like Allergan Aesthetics (AbbVie Inc.), Merz Aesthetics, Cynosure LLC, and others actively operating in the ma rket.

Market Dynamics: Drivers & Restraints

Increasing demand for plastic surgery procedures

The increasing demand for plastic surgery procedures is expected to be a significant factor in the growth of the global plastic surgery market. Factors such as the increasing geriatric population, increase in the number of scars and injuries, technological advancements, recent launches, and approvals increase the demand for plastic surgery procedures. The growing geriatric population is expected to have a substantial impact on the global plastic surgery market. As life expectancy increases and the older population grows, there is a greater need for aesthetic treatments that address age-related issues such as wrinkles, sagging skin, and volume loss. Facelifts, dermal fillers, and Botox injections are becoming increasingly popular among elderly individuals as a way to improve their appearance.

The rising occurrence of traffic accidents and burn injuries has resulted in a greater number of patients requiring scar therapy, driving up demand for various plastic surgery operations aimed at scar revision and aesthetic improvement. For instance, according to the World Health Organization, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year.

The number of procedures performed is increasing day by day due to the need for beautification and to improve appearance. For instance, according to the American Society of Plastic Surgeons, in 2023, in the US, a total of 304,181 Breast augmentation procedures, 347,782 liposuction procedures, and 120,747 eyelid surgeries and procedures were performed.

The increasing geriatric population is the major driver for market growth in the forecast period. As the geriatric population across the globe is rising, the demand for plastic surgery is increasing. For instance, as per the United Nations, in 2023, the global population above 60 years of age accounted for 1.06 billion, and the same age group population is expected to rise to 1.33 billion in 2030. For the increasing geriatric population, there are recent launches for plastic surgery and treatment. For instance, in September 2024, Allergan Aesthetics, an AbbVie company announced that BOTOX Cosmetic (onabotulinumtoxinA) is now available in China to treat masseter muscle predominance (MMP). The masseter muscle is one of the lower face's chewing muscles, and its predominance can result in a wide and square lower face shape1. The China National Medical Product Administration (NMPA) recently approved BOTOX Cosmetic to temporarily enhance the appearance of significant to extremely marked MMP in adults. BOTOX Cosmetic is the first neurotoxin approved in China for MMP, and it includes the defined dose, strong clinical data, and physician training associated with on-label treatment.

Side effects associated with plastic surgery

Factors such as side effects associated with plastic surgery are expected to hamper the global plastic surgery market. Infections, severe bleeding, scarring, and anesthetic or implant-related adverse responses are all common problems. These dangers not only endanger patient safety, but they can also lead to dissatisfaction with results, resulting in legal liability for practitioners and harming their professional reputations. For instance, according to the National Institute of Health, long-term adverse events such as persistent granulomas and infections are being reported. These may be due to laxity in aseptic procedures or the formation of biofilms. Adverse events with fillers can not only be persistent but can also lead to serious complications such as permanent blindness.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type gender, age group, end-user, and region.

The cosmetic (minimally-invasive) procedures segment is expected to dominate the global plastic surgery market share

The segment of minimally invasive cosmetic operations is expected to dominate the global plastic surgery market as a result of technical improvements, patient preferences, recent launches with technological advancements, and the inherent benefits of these procedures. Minimally invasive therapies, such as Botox injections, dermal fillers, and laser treatments, have grown in favor since they often require minimal incisions or none at all. This strategy lessens the physical damage associated with standard operations, as well as scars and recovery time, making these solutions more appealing to a broader audience.

Due to increasing demand for minimally invasive procedures, there are so many new launches, especially in the lasers section. For instance, in September 2023, Cutera, Inc. a global leader in aesthetic and dermatology solutions, announced the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies. Each modality can be used individually or in combination to target a wide range of aesthetic indications. It is Optimized to treat varying layers of the skin; the Secret DUO is equipped with a radio frequency microneedling (RFMN) handpiece along with a fractional non-ablative 1540 nm erbium glass laser. The unique pairing of these modalities allows practitioners to provide fully customizable solutions for fine lines, texture, pigment, stretch marks, and scars.

Geographical Analysis

North America is expected to hold a significant position in the global plastic surgery market share

North America is expected to hold a significant portion of the global plastic surgery market. North America is anticipated to play a leading position in the global plastic surgery market owing to various factors such as the increasing geriatric population, technological advancements, recent launches and approvals, and the presence of strong players in this region. In this region, there is an increasing geriatric population which leads growth of the market in this region due to skin issues faced by the geriatric population. For instance, according to the Pew Research Center, the number of Americans ages 100 and older is projected to more than quadruple over the next three decades, from an estimated 101,000 in 2024 to about 422,000 in 2054, according to projections from the U.S. Census Bureau.

Due to the presence of the major players, there are recent launches and approvals in this region which makes this region hold a significant position in the global plastic surgery market. For instance, in January 2023, Reveal Lasers LLC announced the launch of the AlloraPro Laser Workstation, a state-of-the-art device designed for permanent hair reduction and skin rejuvenation treatments. The device's intuitive user interface has color-coded screens based on the active wavelength, allowing professionals to customize treatments for each patient. The strategic partnerships in this region are also one of the main reasons for the market to prosper in this region. For instance, in January 2024, United Aesthetics Alliance established to consolidate market-leading, clinically differentiated plastic surgery practices and affiliated medical spa service providers, announced that it has formed a new partnership with the Bengtson Center for Aesthetics & Plastic Surgery. BCAPS, headquartered in Grand Rapids, MI, is a leading plastic surgery and aesthetics provider in West Michigan and it is led by two recognized board-certified plastic surgeons.

Asia Pacific is growing at the fastest pace in the global plastic surgery market

The Asia Pacific region is witnessing rapid expansion in the plastic surgery market, propelled by economic advancement, an increasing geriatric population, and technological advancements. This expansion is especially evident in nations such as Korea, Japan, and India, where investments in dermatology, skincare, and wellness, and awareness about plastic surgery procedures have been increasing day by day during recent times. There are recent approvals and launches in this region which propels the market. For instance, in May 2024, Korean startup MediThinQ announced the launch of its SCOPEYE 3D Micro Surgery Solution, which uses the latest Eyes Up Display technology for improving precision across medical specialties. The SCOPEYE 3D Micro Surgery Solution's portability and space-saving features make it suitable for a wide array of medical procedures, including microsurgery, dental procedures, plastic surgery, ophthalmology, hair transplant surgery, and dermatology.

Competitive Landscape

The major global players in the global plastic surgery market include Allergan Aesthetics (AbbVie Inc.), Alma Lasers, Cynosure LLC, Galderma, Bausch Health Companies Inc., Merz Aesthetics, Candela Corporation, Evolus, Inc., Lumenis Be Ltd., GC Aesthetics among others.

Emerging Players

MediThinQ, Avance Innovation, and ReConstruct Bio among others

Key Developments

In May 2023, the U.S. FDA approved SKINVIVE by JUVEDERM for enhancing the skin softness of the cheeks in individuals over the age of 21, according to a statement from Allergan Aesthetics, a division of AbbVie. The sole and first intradermal microdroplet injection of hyaluronic acid (HA) for skin smoothness to be made available in the United States is called SKINVIVE by JUVEDERM. With proper care, benefits can last up to six months. Smooth, injectable HA gel called SKINVIVE by JUVEDERM includes a trace dose of lidocaine, a local anesthetic.
In June 2023, Restylane Eyelight was approved by the U.S. Food and Drug Administration (FDA) for the treatment of dark shadows under the eyes in individuals over the age of 21. The first and sole product in the United States designed using NASHA Technology addressing volume loss beneath the eyes, Restylane Eyelight is a dermal filler made of hyaluronic acid (HA) that gives patients results that seem natural.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global plastic surgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Surgical Procedure Type
3.2. Snippet by Gender
3.3. Snippet by Age Group
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Geriatric Population
- 4.1.2. Restraints
  - 4.1.2.1. Side Effects Associated with Aesthetic Lasers
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Surgical Procedure Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 6.1.2. Market Attractiveness Index, By Surgical Procedure Type
6.2. Reconstructive Surgical Procedure*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cosmetic (aesthetic) Surgical Procedure
6.4. Cosmetic (Minimally-Invasive) Procedures

7. By Gender

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 7.1.2. Market Attractiveness Index, By Gender
7.2. Female*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Male

8. By Age Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. 13-19 yrs*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. 20-29 yrs
8.4. 30-39 yrs
8.5. 40-54 yrs
8.6. 55-69 yrs
8.7. 70+ yrs

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Surgical Centers/ Clinics
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Allergan Aesthetics (AbbVie Inc.)*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Alma Lasers
12.3. Cynosure LLC
12.4. Galderma
12.5. Bausch Health Companies Inc.
12.6. Merz Aesthetics
12.7. Candela Corporation
12.8. Evolus, Inc.
12.9. Lumenis Be Ltd.
12.10. GC Aesthetics.

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球整形外科市场 - 2024-2031

Global Plastic Surgery Market - 2024-2031

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依手术程序类型

第 7 章：按性别

第 8 章：依年龄组

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录